Health and Social Care Secretary Wes Streeting confirmed on 13 April 2026 that the BMA resident doctor strikes have ended, thanking NHS staff for "working around the clock during industrial action." The announcement marks the conclusion of a dispute that has periodically disrupted NHS primary and secondary care services since 2023.
For community pharmacy, the end of industrial action removes one of the external demand drivers that has shaped walk-in consultation volumes over the past three years. But the structural forces that pushed patients towards pharmacies during strikes — GP access bottlenecks, Pharmacy First, and changing public behaviour — are not going away.
What the strikes meant for pharmacy
During periods of resident doctor industrial action, GP practices and A&E departments experienced reduced capacity. Patients seeking routine consultations, minor illness treatment, and prescription queries were redirected — formally and informally — to community pharmacies.
Pharmacy First, the NHS England service launched in January 2024, formalised much of this redirection. Under Pharmacy First, pharmacists can assess and treat seven common conditions (sinusitis, sore throat, earache, infected insect bites, impetigo, shingles, and uncomplicated UTIs in women) without a GP referral. The service pays pharmacies a £15 consultation fee, with PharmSee estimating that urban pharmacies conducting around 400 Pharmacy First consultations per year could generate approximately £6,000 in additional revenue per site.
The strikes accelerated public awareness of Pharmacy First and walk-in pharmacy services more broadly. That behavioural shift — patients choosing to visit a pharmacy rather than queue for a GP appointment — is unlikely to reverse simply because the strikes have ended.
The workforce question remains
The end of strikes resolves the immediate disruption but does not address the underlying workforce pressures that affect both medicine and pharmacy. PharmSee currently tracks 1,327 active pharmacy vacancies across 11 employer sources in England:
| Source | Vacancies |
|---|---|
| Boots | 540 |
| NHS Jobs | 461 |
| Cohens | 65 |
| Asda | 54 |
| Superdrug | 50 |
| Tesco | 43 |
| Weldricks | 37 |
| Morrisons | 32 |
| Rowlands | 20 |
| Day Lewis | 15 |
| Well | 10 |
The NHS Jobs figure of 461 pharmacy-specific listings indicates that hospital and clinical pharmacy demand remains robust. These roles — including ward pharmacists, clinical specialists, and independent prescribers — were never directly affected by resident doctor strikes, but the broader NHS staffing environment shapes how quickly trusts can fill them.
What to expect
Three near-term effects are plausible, though none are certain:
1. Walk-in volumes may stabilise, not decline. The pre-strike trajectory was already towards more pharmacy-based minor illness management. The DHSC's long-term NHS workforce plan explicitly expands pharmacist clinical roles. Patients who discovered Pharmacy First during strike periods may continue to use it.
2. GP referral patterns may not change immediately. During strikes, some GP practices developed informal referral relationships with neighbouring pharmacies. Whether these persist without the pressure of reduced GP capacity will vary by practice and locality.
3. Pharmacy First revenue ceiling is unchanged. The £15 per-consultation fee and the scope of conditions covered are set by NHS England and are unrelated to industrial action. The end of strikes does not change the economic proposition of Pharmacy First for pharmacy owners — the service's value depends on local consultation volume, not on whether GPs are on strike.
The data gap
One limitation of this analysis is that PharmSee does not track Pharmacy First consultation volumes directly. The NHSBSA publishes aggregate Pharmacy First data, but with a reporting lag of several months. It is therefore not possible to quantify precisely how much the strikes contributed to pharmacy walk-in demand versus the underlying growth trend.
What PharmSee can say, based on its dispensing data covering 13,147 pharmacies and 5.3 million dispensing records, is that community pharmacy infrastructure remains intact and operating at scale. The 1,327 active vacancies suggest the sector is still hiring to meet demand — not contracting.
For pharmacy professionals monitoring the job market, PharmSee's job board tracks all 11 employer sources in real time. Dispensing data by area is available on the pharmacy search tool, and Pharmacy First's position in the service mix can be explored via the salary guides.
Sources: Health Secretary statement on end of BMA Resident Doctor strikes, GOV.UK, 13 April 2026. PharmSee job tracker (11 sources, snapshot 13 April 2026). Pharmacy First revenue estimates are PharmSee analytical estimates based on NHS England fee schedules and are not measured consultation volumes.